| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 87 | 2024 | 3111 | 9.360 |
Why?
|
| Thymus Gland | 75 | 2024 | 1261 | 8.210 |
Why?
|
| Histocompatibility Antigens Class II | 75 | 2017 | 1441 | 4.710 |
Why?
|
| Intra-Abdominal Fat | 14 | 2024 | 623 | 4.400 |
Why?
|
| T-Lymphocytes | 98 | 2024 | 10261 | 3.860 |
Why?
|
| Immune Tolerance | 30 | 2024 | 2324 | 3.550 |
Why?
|
| Diabetes Mellitus, Type 1 | 61 | 2021 | 3446 | 3.220 |
Why?
|
| Transcription Factors | 60 | 2024 | 12131 | 3.110 |
Why?
|
| Autoimmunity | 41 | 2022 | 1354 | 2.890 |
Why?
|
| Mice, Inbred NOD | 81 | 2023 | 1837 | 2.870 |
Why?
|
| Receptors, Antigen, T-Cell | 59 | 2023 | 2570 | 2.500 |
Why?
|
| Mice | 333 | 2025 | 81818 | 2.450 |
Why?
|
| Forkhead Transcription Factors | 41 | 2024 | 1624 | 2.400 |
Why?
|
| CD4-Positive T-Lymphocytes | 61 | 2021 | 4405 | 2.320 |
Why?
|
| Epithelial Cells | 20 | 2024 | 3681 | 2.310 |
Why?
|
| Islets of Langerhans | 32 | 2019 | 1349 | 2.070 |
Why?
|
| Genes, MHC Class II | 33 | 2007 | 433 | 2.020 |
Why?
|
| Animals | 373 | 2025 | 168759 | 1.970 |
Why?
|
| Mice, Transgenic | 106 | 2022 | 9550 | 1.950 |
Why?
|
| Polyendocrinopathies, Autoimmune | 9 | 2020 | 56 | 1.950 |
Why?
|
| Adipose Tissue | 12 | 2024 | 3312 | 1.940 |
Why?
|
| T-Lymphocyte Subsets | 24 | 2021 | 1811 | 1.710 |
Why?
|
| Cell Differentiation | 63 | 2024 | 11640 | 1.700 |
Why?
|
| Arthritis | 15 | 2012 | 677 | 1.670 |
Why?
|
| Autoimmune Diseases | 31 | 2017 | 2226 | 1.640 |
Why?
|
| Muscle, Skeletal | 10 | 2023 | 4959 | 1.630 |
Why?
|
| Regeneration | 8 | 2022 | 1517 | 1.570 |
Why?
|
| Arthritis, Experimental | 14 | 2016 | 288 | 1.540 |
Why?
|
| Mice, Inbred C57BL | 96 | 2025 | 22331 | 1.540 |
Why?
|
| Gene Expression Regulation | 55 | 2025 | 11888 | 1.450 |
Why?
|
| Self Tolerance | 11 | 2015 | 119 | 1.450 |
Why?
|
| B-Lymphocytes | 32 | 2024 | 4778 | 1.350 |
Why?
|
| Adipocytes | 7 | 2024 | 1194 | 1.330 |
Why?
|
| Inflammation | 33 | 2025 | 10850 | 1.220 |
Why?
|
| Homeostasis | 14 | 2024 | 3336 | 1.190 |
Why?
|
| Autoantigens | 18 | 2010 | 883 | 1.170 |
Why?
|
| Interleukin-17 | 5 | 2022 | 921 | 1.140 |
Why?
|
| Major Histocompatibility Complex | 23 | 2005 | 879 | 1.110 |
Why?
|
| Clonal Deletion | 10 | 2012 | 75 | 1.070 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 21 | 2013 | 813 | 1.070 |
Why?
|
| Spleen | 15 | 2021 | 2296 | 1.020 |
Why?
|
| Models, Immunological | 13 | 2021 | 517 | 1.010 |
Why?
|
| Arthritis, Rheumatoid | 18 | 2013 | 3733 | 0.980 |
Why?
|
| Killer Cells, Natural | 9 | 2025 | 2210 | 0.960 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 8 | 2024 | 151 | 0.940 |
Why?
|
| Colon | 6 | 2023 | 1795 | 0.940 |
Why?
|
| Autoantibodies | 20 | 2012 | 2113 | 0.920 |
Why?
|
| DNA, Z-Form | 1 | 2024 | 3 | 0.920 |
Why?
|
| Transcription, Genetic | 36 | 2025 | 7599 | 0.880 |
Why?
|
| Mice, Knockout | 55 | 2024 | 14447 | 0.860 |
Why?
|
| Insulin-Secreting Cells | 9 | 2019 | 898 | 0.860 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2023 | 126 | 0.830 |
Why?
|
| PPAR gamma | 3 | 2018 | 483 | 0.830 |
Why?
|
| Complement System Proteins | 3 | 2022 | 715 | 0.810 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2023 | 1663 | 0.810 |
Why?
|
| CD8-Positive T-Lymphocytes | 28 | 2017 | 4642 | 0.790 |
Why?
|
| Species Specificity | 7 | 2024 | 2406 | 0.770 |
Why?
|
| Macrophages | 13 | 2024 | 5772 | 0.750 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2022 | 353 | 0.730 |
Why?
|
| Lymphocyte Activation | 31 | 2022 | 5501 | 0.730 |
Why?
|
| Metagenome | 4 | 2012 | 464 | 0.730 |
Why?
|
| Disease Models, Animal | 40 | 2021 | 18294 | 0.720 |
Why?
|
| Interferon-gamma | 12 | 2023 | 3160 | 0.720 |
Why?
|
| Gene Expression Profiling | 38 | 2024 | 9524 | 0.720 |
Why?
|
| Immune System | 6 | 2019 | 799 | 0.690 |
Why?
|
| Muscle Development | 1 | 2022 | 257 | 0.690 |
Why?
|
| Nociceptors | 2 | 2024 | 465 | 0.680 |
Why?
|
| Glucose-6-Phosphate Isomerase | 9 | 2010 | 49 | 0.680 |
Why?
|
| PPAR alpha | 1 | 2021 | 176 | 0.660 |
Why?
|
| Obesity | 13 | 2024 | 13075 | 0.650 |
Why?
|
| Th17 Cells | 6 | 2024 | 786 | 0.650 |
Why?
|
| Chromatin | 11 | 2024 | 2980 | 0.650 |
Why?
|
| Insulin Resistance | 6 | 2024 | 3985 | 0.650 |
Why?
|
| Immunologic Memory | 12 | 2019 | 1375 | 0.640 |
Why?
|
| Antigen Presentation | 13 | 2017 | 1250 | 0.620 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 8 | 2000 | 318 | 0.620 |
Why?
|
| Promoter Regions, Genetic | 16 | 2024 | 5786 | 0.610 |
Why?
|
| Clonal Anergy | 1 | 2019 | 169 | 0.610 |
Why?
|
| DNA Nucleotidylexotransferase | 8 | 1996 | 64 | 0.590 |
Why?
|
| Lymphocytes | 8 | 2025 | 2599 | 0.580 |
Why?
|
| Digestive System | 2 | 2020 | 244 | 0.580 |
Why?
|
| Mice, Mutant Strains | 19 | 2014 | 1745 | 0.580 |
Why?
|
| Antigen-Presenting Cells | 17 | 2003 | 962 | 0.580 |
Why?
|
| DNA-Binding Proteins | 23 | 2020 | 9601 | 0.570 |
Why?
|
| Molecular Sequence Data | 54 | 2015 | 17594 | 0.560 |
Why?
|
| Intestines | 7 | 2024 | 1906 | 0.550 |
Why?
|
| Interferon-alpha | 1 | 2021 | 910 | 0.550 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2017 | 1365 | 0.540 |
Why?
|
| Pancreas | 16 | 2017 | 1700 | 0.540 |
Why?
|
| Antigens, Differentiation | 5 | 2006 | 919 | 0.540 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2017 | 108 | 0.530 |
Why?
|
| Single-Cell Analysis | 10 | 2024 | 2536 | 0.520 |
Why?
|
| Cell Lineage | 19 | 2014 | 2573 | 0.520 |
Why?
|
| Immunity | 4 | 2015 | 1002 | 0.520 |
Why?
|
| Histocompatibility Antigens Class I | 13 | 2001 | 1365 | 0.520 |
Why?
|
| Immunomodulation | 1 | 2020 | 547 | 0.510 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 632 | 0.510 |
Why?
|
| Bacteria | 6 | 2021 | 2209 | 0.500 |
Why?
|
| Stromal Cells | 6 | 2024 | 1329 | 0.500 |
Why?
|
| Cytokines | 16 | 2025 | 7421 | 0.500 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2015 | 42 | 0.490 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 1744 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 12240 | 0.490 |
Why?
|
| Receptors, IgG | 4 | 2010 | 559 | 0.490 |
Why?
|
| Gene Expression | 12 | 2016 | 7584 | 0.480 |
Why?
|
| Base Sequence | 44 | 2011 | 12403 | 0.470 |
Why?
|
| Flow Cytometry | 25 | 2021 | 5881 | 0.460 |
Why?
|
| Antigens, CD | 16 | 2015 | 4025 | 0.460 |
Why?
|
| Dendritic Cells | 6 | 2021 | 2747 | 0.460 |
Why?
|
| RNA, Messenger | 16 | 2018 | 12769 | 0.450 |
Why?
|
| Adipose Tissue, Brown | 3 | 2020 | 776 | 0.450 |
Why?
|
| H-2 Antigens | 8 | 1997 | 359 | 0.450 |
Why?
|
| Mice, Inbred Strains | 14 | 2016 | 1770 | 0.440 |
Why?
|
| Bacteroidaceae Infections | 1 | 2013 | 32 | 0.440 |
Why?
|
| Prevotella | 1 | 2013 | 81 | 0.430 |
Why?
|
| Denervation | 1 | 2014 | 265 | 0.420 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2019 | 1118 | 0.420 |
Why?
|
| Peptides | 15 | 2015 | 4331 | 0.420 |
Why?
|
| Zebrafish | 1 | 2024 | 3035 | 0.420 |
Why?
|
| Receptors, Complement | 2 | 2012 | 240 | 0.420 |
Why?
|
| Aging | 6 | 2019 | 8731 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2013 | 3796 | 0.410 |
Why?
|
| Mucous Membrane | 1 | 2016 | 657 | 0.410 |
Why?
|
| Amino Acid Sequence | 40 | 2015 | 13400 | 0.410 |
Why?
|
| Lysine | 3 | 2015 | 991 | 0.410 |
Why?
|
| Cells, Cultured | 19 | 2024 | 18973 | 0.410 |
Why?
|
| Organ Specificity | 9 | 2020 | 1965 | 0.400 |
Why?
|
| Mice, Inbred BALB C | 21 | 2020 | 6220 | 0.400 |
Why?
|
| Hindlimb | 1 | 2014 | 510 | 0.390 |
Why?
|
| Mast Cells | 8 | 2014 | 1412 | 0.390 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2010 | 85 | 0.380 |
Why?
|
| Interleukin-1alpha | 2 | 2010 | 88 | 0.380 |
Why?
|
| Mice, Obese | 3 | 2024 | 417 | 0.380 |
Why?
|
| Histones | 7 | 2010 | 2584 | 0.370 |
Why?
|
| Cell Separation | 5 | 2019 | 1718 | 0.370 |
Why?
|
| Lymph Nodes | 15 | 2023 | 3454 | 0.370 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 2013 | 894 | 0.370 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 5 | 2010 | 975 | 0.360 |
Why?
|
| Humans | 131 | 2024 | 765956 | 0.360 |
Why?
|
| Signal Transduction | 18 | 2024 | 23600 | 0.360 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2590 | 0.360 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2010 | 379 | 0.350 |
Why?
|
| Immunoglobulins | 6 | 2002 | 852 | 0.350 |
Why?
|
| Thinness | 2 | 2014 | 482 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 7 | 2007 | 825 | 0.340 |
Why?
|
| Antigens | 6 | 2023 | 1438 | 0.340 |
Why?
|
| Interleukin-4 | 5 | 2008 | 1162 | 0.340 |
Why?
|
| Phenotype | 21 | 2021 | 16721 | 0.340 |
Why?
|
| Allergy and Immunology | 3 | 2012 | 169 | 0.340 |
Why?
|
| HEK293 Cells | 7 | 2021 | 4258 | 0.340 |
Why?
|
| Microvessels | 1 | 2014 | 591 | 0.340 |
Why?
|
| Protein Binding | 14 | 2017 | 9296 | 0.330 |
Why?
|
| Genetic Vectors | 9 | 2006 | 3404 | 0.330 |
Why?
|
| Genome | 4 | 2021 | 1753 | 0.330 |
Why?
|
| Immunity, Innate | 10 | 2017 | 3081 | 0.330 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2024 | 331 | 0.330 |
Why?
|
| Neutrophils | 7 | 2023 | 3776 | 0.320 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2000 | 792 | 0.320 |
Why?
|
| Intestinal Mucosa | 3 | 2016 | 3046 | 0.320 |
Why?
|
| Interleukin-2 | 4 | 2013 | 1896 | 0.310 |
Why?
|
| Antibodies | 8 | 2010 | 2417 | 0.310 |
Why?
|
| Biodiversity | 1 | 2011 | 346 | 0.310 |
Why?
|
| Genetic Variation | 13 | 2024 | 6610 | 0.310 |
Why?
|
| Neuroimmunomodulation | 2 | 2024 | 186 | 0.300 |
Why?
|
| Epitopes | 14 | 1999 | 2523 | 0.300 |
Why?
|
| Male | 66 | 2024 | 363691 | 0.300 |
Why?
|
| Symbiosis | 6 | 2017 | 297 | 0.300 |
Why?
|
| Adipogenesis | 2 | 2024 | 369 | 0.290 |
Why?
|
| Lymphotoxin-alpha | 1 | 2007 | 94 | 0.290 |
Why?
|
| Gastrointestinal Tract | 3 | 2022 | 834 | 0.280 |
Why?
|
| Lymphocyte Count | 6 | 2012 | 790 | 0.280 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2012 | 446 | 0.280 |
Why?
|
| Nuclear Proteins | 5 | 2015 | 5783 | 0.280 |
Why?
|
| Cell Communication | 3 | 2020 | 1660 | 0.280 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1187 | 0.270 |
Why?
|
| Organ Culture Techniques | 5 | 2017 | 788 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 14 | 2013 | 9249 | 0.270 |
Why?
|
| Cell Division | 7 | 2004 | 4475 | 0.270 |
Why?
|
| Plasma Cells | 1 | 2010 | 591 | 0.260 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2015 | 548 | 0.260 |
Why?
|
| Genes, Reporter | 4 | 2014 | 1524 | 0.260 |
Why?
|
| Immunity, Active | 1 | 2006 | 58 | 0.260 |
Why?
|
| Germ-Free Life | 4 | 2017 | 187 | 0.260 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 146 | 0.260 |
Why?
|
| Leukocytes | 1 | 2014 | 2027 | 0.250 |
Why?
|
| Hybridomas | 11 | 2003 | 442 | 0.250 |
Why?
|
| Interleukin-1beta | 2 | 2010 | 1028 | 0.250 |
Why?
|
| Interleukin-7 | 3 | 2013 | 147 | 0.250 |
Why?
|
| Alleles | 15 | 2023 | 6897 | 0.250 |
Why?
|
| Mutation | 31 | 2023 | 30196 | 0.250 |
Why?
|
| Complement C3 | 1 | 2007 | 424 | 0.250 |
Why?
|
| beta 2-Microglobulin | 5 | 1999 | 330 | 0.240 |
Why?
|
| Natural Killer T-Cells | 2 | 2013 | 319 | 0.240 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2006 | 545 | 0.240 |
Why?
|
| Chromosome Mapping | 12 | 2017 | 4618 | 0.240 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2011 | 3401 | 0.240 |
Why?
|
| Cell Proliferation | 13 | 2021 | 10429 | 0.240 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 3819 | 0.240 |
Why?
|
| Endocarditis | 1 | 2009 | 350 | 0.240 |
Why?
|
| Interleukin-6 | 5 | 2025 | 3222 | 0.240 |
Why?
|
| Stem Cells | 5 | 2016 | 3540 | 0.240 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2006 | 561 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2005 | 3737 | 0.230 |
Why?
|
| Epithelium | 2 | 2008 | 1599 | 0.230 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 147 | 0.230 |
Why?
|
| Biological Evolution | 3 | 2024 | 1072 | 0.230 |
Why?
|
| Venoms | 3 | 2015 | 94 | 0.230 |
Why?
|
| Adoptive Transfer | 5 | 2021 | 827 | 0.230 |
Why?
|
| Oncostatin M | 1 | 2024 | 42 | 0.230 |
Why?
|
| Cell Transplantation | 1 | 2006 | 473 | 0.220 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2024 | 604 | 0.220 |
Why?
|
| Thermogenesis | 2 | 2020 | 496 | 0.220 |
Why?
|
| Insulin | 10 | 2019 | 6599 | 0.210 |
Why?
|
| Female | 55 | 2024 | 396101 | 0.210 |
Why?
|
| Lymphoid Tissue | 5 | 2013 | 444 | 0.210 |
Why?
|
| Molecular Mimicry | 2 | 2001 | 210 | 0.210 |
Why?
|
| Polymorphism, Genetic | 9 | 1995 | 4247 | 0.210 |
Why?
|
| Coculture Techniques | 2 | 2024 | 1336 | 0.200 |
Why?
|
| Culture Media, Conditioned | 1 | 2024 | 522 | 0.200 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 237 | 0.200 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1984 | 0.200 |
Why?
|
| Joints | 6 | 2010 | 321 | 0.200 |
Why?
|
| HLA-D Antigens | 3 | 1998 | 130 | 0.200 |
Why?
|
| CpG Islands | 1 | 2007 | 1207 | 0.200 |
Why?
|
| Myeloid Cells | 2 | 2025 | 839 | 0.200 |
Why?
|
| Mitochondria, Muscle | 1 | 2023 | 170 | 0.200 |
Why?
|
| Quantitative Trait Loci | 7 | 2015 | 2140 | 0.200 |
Why?
|
| Immunity, Mucosal | 2 | 2016 | 498 | 0.200 |
Why?
|
| Muramidase | 5 | 2002 | 163 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 4562 | 0.200 |
Why?
|
| Haplotypes | 9 | 2010 | 2728 | 0.200 |
Why?
|
| Phosphorylation | 6 | 2015 | 8278 | 0.200 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 98 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2008 | 4752 | 0.190 |
Why?
|
| Up-Regulation | 6 | 2010 | 4137 | 0.190 |
Why?
|
| Gene Regulatory Networks | 5 | 2017 | 1749 | 0.190 |
Why?
|
| Adenoviridae | 4 | 2000 | 1092 | 0.190 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 3 | 1999 | 32 | 0.190 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 529 | 0.190 |
Why?
|
| Binding Sites | 11 | 2017 | 6001 | 0.190 |
Why?
|
| Immunoconjugates | 2 | 2000 | 981 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 11 | 2016 | 6069 | 0.190 |
Why?
|
| Prediabetic State | 2 | 2008 | 548 | 0.190 |
Why?
|
| Heligmosomatoidea | 1 | 2021 | 2 | 0.190 |
Why?
|
| Lipolysis | 1 | 2022 | 211 | 0.190 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 4 | 1993 | 113 | 0.180 |
Why?
|
| Dermatitis | 1 | 2023 | 199 | 0.180 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 385 | 0.180 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2006 | 746 | 0.180 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2021 | 64 | 0.180 |
Why?
|
| Nanostructures | 1 | 2005 | 548 | 0.170 |
Why?
|
| RNA Splicing | 3 | 2015 | 903 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 852 | 0.170 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.170 |
Why?
|
| Succinic Acid | 1 | 2020 | 86 | 0.170 |
Why?
|
| Cell Survival | 5 | 2019 | 5746 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1490 | 0.160 |
Why?
|
| Stearic Acids | 1 | 2019 | 56 | 0.160 |
Why?
|
| Transfection | 8 | 2000 | 5743 | 0.160 |
Why?
|
| Inflammasomes | 1 | 2024 | 543 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2004 | 2666 | 0.160 |
Why?
|
| Cloning, Molecular | 10 | 1997 | 4165 | 0.160 |
Why?
|
| Genes, Homeobox | 3 | 1989 | 287 | 0.160 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1718 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2019 | 260 | 0.160 |
Why?
|
| Adaptive Immunity | 4 | 2017 | 734 | 0.160 |
Why?
|
| Wound Healing | 2 | 2023 | 2792 | 0.160 |
Why?
|
| Immunogenetic Phenomena | 2 | 2016 | 23 | 0.160 |
Why?
|
| Histocompatibility Antigens | 5 | 2013 | 477 | 0.160 |
Why?
|
| DNA | 18 | 2017 | 7202 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 147 | 0.150 |
Why?
|
| Immune System Diseases | 1 | 2021 | 251 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3750 | 0.150 |
Why?
|
| Janus Kinases | 2 | 2016 | 253 | 0.150 |
Why?
|
| Cardiotoxins | 1 | 2018 | 35 | 0.150 |
Why?
|
| Capsid Proteins | 1 | 2001 | 467 | 0.150 |
Why?
|
| Th2 Cells | 5 | 2012 | 1075 | 0.150 |
Why?
|
| Enteric Nervous System | 1 | 2021 | 213 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 1216 | 0.140 |
Why?
|
| Protein Kinase C | 1 | 2002 | 1202 | 0.140 |
Why?
|
| Skin Diseases | 2 | 2023 | 1088 | 0.140 |
Why?
|
| Models, Biological | 5 | 2015 | 9443 | 0.140 |
Why?
|
| Ligands | 7 | 2024 | 3273 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2019 | 398 | 0.140 |
Why?
|
| Proteomics | 3 | 2010 | 3910 | 0.140 |
Why?
|
| Muscles | 1 | 2022 | 1578 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 4 | 2025 | 271 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 385 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 243 | 0.140 |
Why?
|
| Interleukin-1 | 3 | 2007 | 1243 | 0.140 |
Why?
|
| Disease Progression | 10 | 2017 | 13631 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 520 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2013 | 1995 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2017 | 1644 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2021 | 2927 | 0.140 |
Why?
|
| NF-kappa B | 4 | 2025 | 2485 | 0.140 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2892 | 0.140 |
Why?
|
| Clostridium | 1 | 2017 | 100 | 0.130 |
Why?
|
| Genes, Dominant | 3 | 2000 | 856 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 6 | 1994 | 287 | 0.130 |
Why?
|
| Lipoproteins | 1 | 2001 | 866 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 1740 | 0.130 |
Why?
|
| Retroviridae | 2 | 2006 | 847 | 0.130 |
Why?
|
| Diet | 3 | 2024 | 8086 | 0.130 |
Why?
|
| Transgenes | 4 | 2009 | 1015 | 0.130 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1993 | 419 | 0.130 |
Why?
|
| Monocytes | 3 | 2014 | 2595 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3807 | 0.130 |
Why?
|
| Antigens, CD1 | 2 | 1995 | 435 | 0.130 |
Why?
|
| Kinetics | 6 | 2007 | 6274 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2024 | 229 | 0.130 |
Why?
|
| Interleukin-15 | 2 | 2010 | 186 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2020 | 705 | 0.130 |
Why?
|
| Genomics | 5 | 2012 | 5929 | 0.130 |
Why?
|
| Mice, Inbred DBA | 4 | 1999 | 623 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2014 | 16047 | 0.120 |
Why?
|
| Guanidines | 1 | 1996 | 194 | 0.120 |
Why?
|
| Immunosuppressive Agents | 4 | 2009 | 4209 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 3 | 2009 | 508 | 0.120 |
Why?
|
| Animals, Newborn | 4 | 1995 | 2669 | 0.120 |
Why?
|
| Stochastic Processes | 3 | 2008 | 358 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 453 | 0.120 |
Why?
|
| Recombination, Genetic | 4 | 2000 | 1525 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 2194 | 0.120 |
Why?
|
| Genes, RAG-1 | 1 | 1995 | 67 | 0.120 |
Why?
|
| Psoriasis | 1 | 2023 | 919 | 0.120 |
Why?
|
| Th1 Cells | 3 | 2005 | 1039 | 0.120 |
Why?
|
| Cell Line | 11 | 2014 | 15543 | 0.120 |
Why?
|
| Crosses, Genetic | 6 | 2011 | 752 | 0.120 |
Why?
|
| Acetylation | 3 | 2015 | 1053 | 0.120 |
Why?
|
| Nucleoproteins | 2 | 1993 | 110 | 0.120 |
Why?
|
| Cluster Analysis | 6 | 2014 | 2720 | 0.110 |
Why?
|
| Animals, Outbred Strains | 2 | 2010 | 20 | 0.110 |
Why?
|
| Diarrhea | 1 | 2021 | 1316 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 484 | 0.110 |
Why?
|
| Viral Core Proteins | 2 | 1996 | 158 | 0.110 |
Why?
|
| Photochemical Processes | 1 | 2014 | 84 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2017 | 2850 | 0.110 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 69 | 0.110 |
Why?
|
| Antibody Formation | 5 | 1993 | 1391 | 0.110 |
Why?
|
| Elasticity | 1 | 2015 | 652 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 2817 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 1993 | 2428 | 0.110 |
Why?
|
| Immunophenotyping | 6 | 2015 | 1866 | 0.110 |
Why?
|
| Ribonucleases | 2 | 1991 | 265 | 0.110 |
Why?
|
| Repressor Proteins | 4 | 2013 | 2968 | 0.110 |
Why?
|
| Cyclophosphamide | 3 | 2005 | 2228 | 0.100 |
Why?
|
| Serum | 1 | 2014 | 206 | 0.100 |
Why?
|
| Clone Cells | 6 | 2002 | 1672 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 1241 | 0.100 |
Why?
|
| Paralysis | 1 | 2014 | 248 | 0.100 |
Why?
|
| Receptors, Immunologic | 3 | 2014 | 1415 | 0.100 |
Why?
|
| Immunogenetics | 1 | 2012 | 62 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 1996 | 1801 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1996 | 1347 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2014 | 18071 | 0.100 |
Why?
|
| Genes, Immunoglobulin | 1 | 1993 | 285 | 0.100 |
Why?
|
| Probiotics | 1 | 2016 | 387 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1387 | 0.100 |
Why?
|
| CD4-CD8 Ratio | 3 | 2010 | 114 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2014 | 271 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2009 | 735 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 269 | 0.100 |
Why?
|
| Tetracycline | 3 | 2005 | 216 | 0.100 |
Why?
|
| Graft Rejection | 3 | 1994 | 4499 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2006 | 6493 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2016 | 705 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 11022 | 0.100 |
Why?
|
| RNA Interference | 2 | 2014 | 2832 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 612 | 0.100 |
Why?
|
| Multigene Family | 3 | 2014 | 1080 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1994 | 705 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2010 | 2630 | 0.100 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 66 | 0.100 |
Why?
|
| Mice, Inbred CBA | 4 | 2020 | 439 | 0.100 |
Why?
|
| Interferon Type I | 1 | 2016 | 567 | 0.100 |
Why?
|
| Microarray Analysis | 4 | 2012 | 752 | 0.100 |
Why?
|
| Genes, Regulator | 3 | 1994 | 373 | 0.100 |
Why?
|
| RNA | 3 | 2018 | 2717 | 0.100 |
Why?
|
| Isoenzymes | 1 | 1996 | 1689 | 0.100 |
Why?
|
| Fetus | 3 | 2007 | 1878 | 0.090 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2012 | 171 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 619 | 0.090 |
Why?
|
| Exons | 3 | 1992 | 2391 | 0.090 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2010 | 394 | 0.090 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 239 | 0.090 |
Why?
|
| Ion Channels | 1 | 2016 | 1045 | 0.090 |
Why?
|
| Cell Death | 3 | 2003 | 1679 | 0.090 |
Why?
|
| Models, Molecular | 7 | 2017 | 5379 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2013 | 1965 | 0.090 |
Why?
|
| Peptide Fragments | 6 | 1999 | 5125 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 839 | 0.090 |
Why?
|
| Muscular Dystrophies | 1 | 2013 | 392 | 0.090 |
Why?
|
| Apoptosis | 4 | 2019 | 9514 | 0.090 |
Why?
|
| Fluorescence | 1 | 2013 | 753 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2035 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2015 | 733 | 0.090 |
Why?
|
| Ankle | 1 | 2014 | 353 | 0.090 |
Why?
|
| Skin | 2 | 2023 | 4489 | 0.090 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 2006 | 111 | 0.090 |
Why?
|
| Nucleotides | 1 | 1993 | 451 | 0.090 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 2010 | 4 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 540 | 0.090 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 541 | 0.090 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1993 | 254 | 0.090 |
Why?
|
| Integrases | 2 | 2011 | 520 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 975 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2012 | 7851 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 895 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 371 | 0.090 |
Why?
|
| Epididymis | 1 | 2012 | 226 | 0.090 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2010 | 58 | 0.090 |
Why?
|
| Radiation Chimera | 2 | 2002 | 216 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1991 | 430 | 0.090 |
Why?
|
| Structure-Activity Relationship | 6 | 1994 | 3051 | 0.080 |
Why?
|
| Hybridization, Genetic | 2 | 2001 | 102 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3430 | 0.080 |
Why?
|
| Chromosome Deletion | 5 | 1999 | 1385 | 0.080 |
Why?
|
| Ferric Compounds | 1 | 2012 | 368 | 0.080 |
Why?
|
| Genetics, Population | 3 | 2015 | 943 | 0.080 |
Why?
|
| Protein Conformation | 6 | 2017 | 3946 | 0.080 |
Why?
|
| Albumins | 1 | 1992 | 577 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 241 | 0.080 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1989 | 52 | 0.080 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2010 | 111 | 0.080 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 605 | 0.080 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2011 | 368 | 0.080 |
Why?
|
| Transformation, Genetic | 1 | 1989 | 194 | 0.080 |
Why?
|
| Introns | 1 | 1992 | 966 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2643 | 0.080 |
Why?
|
| Plasmids | 4 | 2000 | 2274 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3606 | 0.080 |
Why?
|
| Bacteriocins | 1 | 2009 | 85 | 0.080 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2010 | 122 | 0.080 |
Why?
|
| Immunity, Cellular | 4 | 2014 | 1555 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 459 | 0.080 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 198 | 0.080 |
Why?
|
| Cytochrome c Group | 2 | 2000 | 123 | 0.080 |
Why?
|
| Operon | 4 | 1984 | 371 | 0.080 |
Why?
|
| Oligonucleotide Probes | 2 | 2004 | 417 | 0.080 |
Why?
|
| Ovum | 1 | 1989 | 187 | 0.080 |
Why?
|
| Simian virus 40 | 4 | 1984 | 290 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 308 | 0.080 |
Why?
|
| NFATC Transcription Factors | 2 | 2011 | 392 | 0.080 |
Why?
|
| Leukotrienes | 1 | 2010 | 232 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 110 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 305 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2007 | 561 | 0.080 |
Why?
|
| Time Factors | 7 | 2012 | 40065 | 0.070 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1107 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3586 | 0.070 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2013 | 41 | 0.070 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 120 | 0.070 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 190 | 0.070 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2007 | 26 | 0.070 |
Why?
|
| Antibody Specificity | 3 | 2009 | 1061 | 0.070 |
Why?
|
| Androstenes | 1 | 2009 | 178 | 0.070 |
Why?
|
| Membrane Glycoproteins | 4 | 2003 | 3690 | 0.070 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 995 | 0.070 |
Why?
|
| Microsatellite Repeats | 2 | 2001 | 784 | 0.070 |
Why?
|
| Heart | 2 | 2008 | 4414 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 3110 | 0.070 |
Why?
|
| Interleukin-12 | 2 | 2007 | 579 | 0.070 |
Why?
|
| DNA Repair | 1 | 2017 | 2048 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 403 | 0.070 |
Why?
|
| Methylation | 1 | 2010 | 1073 | 0.070 |
Why?
|
| Serine Endopeptidases | 2 | 2012 | 1024 | 0.070 |
Why?
|
| Mucin-6 | 1 | 2007 | 15 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 870 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 36532 | 0.070 |
Why?
|
| Child | 5 | 2024 | 80563 | 0.070 |
Why?
|
| Superantigens | 2 | 1997 | 124 | 0.070 |
Why?
|
| Antibody Affinity | 2 | 2002 | 251 | 0.070 |
Why?
|
| Prodrugs | 1 | 2009 | 273 | 0.070 |
Why?
|
| Blood | 1 | 2009 | 597 | 0.070 |
Why?
|
| Mutagenesis | 3 | 2017 | 1228 | 0.070 |
Why?
|
| Cell Movement | 3 | 2014 | 5194 | 0.070 |
Why?
|
| DNA Damage | 1 | 2017 | 2457 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 691 | 0.070 |
Why?
|
| Lymphopenia | 1 | 2009 | 297 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4913 | 0.070 |
Why?
|
| Diabetes Mellitus | 4 | 2011 | 5891 | 0.070 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1999 | 94 | 0.070 |
Why?
|
| H-Y Antigen | 2 | 1997 | 42 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1657 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3837 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6203 | 0.070 |
Why?
|
| Antigens, Neoplasm | 2 | 2010 | 2002 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 1477 | 0.070 |
Why?
|
| Cross Reactions | 2 | 1999 | 824 | 0.070 |
Why?
|
| Cell Compartmentation | 2 | 1997 | 384 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2010 | 1752 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2012 | 220 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2012 | 951 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2013 | 2195 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2010 | 1997 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.060 |
Why?
|
| Egg Proteins | 2 | 1999 | 58 | 0.060 |
Why?
|
| Tretinoin | 1 | 2008 | 524 | 0.060 |
Why?
|
| Spermatozoa | 1 | 1989 | 629 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2003 | 2159 | 0.060 |
Why?
|
| Histological Techniques | 1 | 2005 | 193 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2012 | 2412 | 0.060 |
Why?
|
| Computational Biology | 4 | 2014 | 3559 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1992 | 1056 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2024 | 22 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1087 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2171 | 0.060 |
Why?
|
| Endocrine System | 1 | 2005 | 111 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2009 | 798 | 0.060 |
Why?
|
| Gene Targeting | 2 | 2011 | 841 | 0.060 |
Why?
|
| GATA6 Transcription Factor | 1 | 2024 | 53 | 0.060 |
Why?
|
| Liver | 2 | 2019 | 7562 | 0.060 |
Why?
|
| Globins | 2 | 2000 | 406 | 0.060 |
Why?
|
| Cathepsins | 1 | 2005 | 242 | 0.060 |
Why?
|
| Binding, Competitive | 3 | 1990 | 1140 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2453 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 865 | 0.060 |
Why?
|
| Skin Transplantation | 3 | 1994 | 1098 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2729 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2024 | 243 | 0.050 |
Why?
|
| DNA Probes | 1 | 2004 | 541 | 0.050 |
Why?
|
| Mucins | 1 | 2007 | 567 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7478 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6113 | 0.050 |
Why?
|
| Carboxypeptidases A | 2 | 2014 | 27 | 0.050 |
Why?
|
| Pedigree | 1 | 2011 | 4526 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2020 | 737 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2004 | 313 | 0.050 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2024 | 164 | 0.050 |
Why?
|
| Viral Proteins | 2 | 2001 | 1797 | 0.050 |
Why?
|
| NIH 3T3 Cells | 2 | 2017 | 651 | 0.050 |
Why?
|
| Adolescent | 6 | 2021 | 88832 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 542 | 0.050 |
Why?
|
| Capillaries | 1 | 2006 | 755 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 2587 | 0.050 |
Why?
|
| Magnetics | 1 | 2005 | 585 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2007 | 3618 | 0.050 |
Why?
|
| Receptors, Glucagon | 2 | 2013 | 90 | 0.050 |
Why?
|
| Mitosis | 1 | 2007 | 1173 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2006 | 768 | 0.050 |
Why?
|
| Terminology as Topic | 3 | 2013 | 1534 | 0.050 |
Why?
|
| Cell Nucleus | 4 | 2020 | 2867 | 0.050 |
Why?
|
| Macromolecular Substances | 4 | 1991 | 1430 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2002 | 115 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2429 | 0.050 |
Why?
|
| Lectins, C-Type | 3 | 2013 | 592 | 0.050 |
Why?
|
| Lyme Disease Vaccines | 1 | 2001 | 18 | 0.050 |
Why?
|
| Biological Transport | 3 | 1996 | 2081 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 1999 | 2548 | 0.050 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22222 | 0.050 |
Why?
|
| Neurons | 1 | 2021 | 9524 | 0.050 |
Why?
|
| Models, Genetic | 4 | 2005 | 3448 | 0.050 |
Why?
|
| Nippostrongylus | 1 | 2021 | 22 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 2 | 1995 | 661 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15880 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2446 | 0.050 |
Why?
|
| Antigens, Surface | 3 | 2001 | 1617 | 0.050 |
Why?
|
| Capsid | 2 | 2001 | 435 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2015 | 4424 | 0.050 |
Why?
|
| Nematospiroides dubius | 1 | 2021 | 37 | 0.050 |
Why?
|
| Keratitis, Herpetic | 1 | 2001 | 76 | 0.050 |
Why?
|
| Protein Multimerization | 2 | 2011 | 959 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2008 | 1611 | 0.040 |
Why?
|
| Salmonella enterica | 1 | 2021 | 75 | 0.040 |
Why?
|
| Rabbits | 2 | 2000 | 4734 | 0.040 |
Why?
|
| Citrobacter rodentium | 1 | 2021 | 64 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1991 | 772 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 81 | 0.040 |
Why?
|
| Cartilage | 1 | 2004 | 798 | 0.040 |
Why?
|
| Succinates | 1 | 2020 | 82 | 0.040 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2020 | 34 | 0.040 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12807 | 0.040 |
Why?
|
| DNA Primers | 2 | 2002 | 2825 | 0.040 |
Why?
|
| DNA, Viral | 3 | 1981 | 2199 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 1365 | 0.040 |
Why?
|
| DNA, Circular | 1 | 1980 | 97 | 0.040 |
Why?
|
| Adenoviruses, Human | 1 | 1981 | 258 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2005 | 3529 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 969 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1996 | 1679 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2674 | 0.040 |
Why?
|
| Age of Onset | 1 | 2007 | 3343 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2005 | 2341 | 0.040 |
Why?
|
| Blood Glucose | 3 | 2013 | 6425 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2021 | 322 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2001 | 400 | 0.040 |
Why?
|
| Peptide Library | 1 | 2020 | 351 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 215 | 0.040 |
Why?
|
| Adult | 8 | 2021 | 223038 | 0.040 |
Why?
|
| Joint Diseases | 1 | 2002 | 459 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2001 | 403 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 649 | 0.040 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1999 | 84 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6499 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1546 | 0.040 |
Why?
|
| Enterovirus B, Human | 1 | 1998 | 47 | 0.040 |
Why?
|
| Esters | 1 | 2019 | 214 | 0.040 |
Why?
|
| Lymphocyte Subsets | 2 | 2006 | 315 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1989 | 848 | 0.040 |
Why?
|
| Hippocampus | 1 | 2010 | 3775 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2001 | 628 | 0.040 |
Why?
|
| Pregnancy | 2 | 2017 | 30258 | 0.040 |
Why?
|
| Ovalbumin | 1 | 1999 | 674 | 0.040 |
Why?
|
| Selection, Genetic | 2 | 1995 | 878 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1808 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 1998 | 268 | 0.040 |
Why?
|
| Symporters | 1 | 2020 | 362 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 572 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4528 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 1997 | 114 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 602 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 2627 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1316 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4427 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 26349 | 0.030 |
Why?
|
| Genome, Human | 2 | 2017 | 4448 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1996 | 511 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 663 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1599 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1998 | 289 | 0.030 |
Why?
|
| Chromatography | 1 | 1996 | 187 | 0.030 |
Why?
|
| Immunoglobulin D | 1 | 1996 | 55 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 1997 | 140 | 0.030 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 1930 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 557 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 252 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 1180 | 0.030 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2017 | 119 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 637 | 0.030 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2019 | 271 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 9347 | 0.030 |
Why?
|
| Young Adult | 3 | 2021 | 59886 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 2477 | 0.030 |
Why?
|
| Chimera | 2 | 1994 | 455 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1995 | 93 | 0.030 |
Why?
|
| Receptors, CXCR3 | 1 | 2016 | 240 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2020 | 1206 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1106 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1892 | 0.030 |
Why?
|
| Overweight | 1 | 2007 | 2443 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 332 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 113 | 0.030 |
Why?
|
| Lyme Disease | 1 | 2001 | 631 | 0.030 |
Why?
|
| Bacteroidetes | 1 | 2015 | 83 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2004 | 2395 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1495 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 14071 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 1724 | 0.030 |
Why?
|
| Synovial Membrane | 2 | 2009 | 513 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1980 | 722 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20125 | 0.030 |
Why?
|
| Gene Rearrangement | 2 | 2007 | 1144 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1995 | 175 | 0.030 |
Why?
|
| Genotype | 4 | 2014 | 13024 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1991 | 421 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 474 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 901 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 1992 | 2086 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 469 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8529 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 209 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 73 | 0.030 |
Why?
|
| Lymphopoiesis | 1 | 2014 | 132 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2004 | 2554 | 0.030 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1993 | 37 | 0.030 |
Why?
|
| TATA-Box Binding Protein | 1 | 1993 | 99 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2003 | 1168 | 0.030 |
Why?
|
| TATA Box | 1 | 1993 | 127 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2015 | 196 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 1993 | 83 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2002 | 1546 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1993 | 189 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 457 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2010 | 1192 | 0.030 |
Why?
|
| Ionomycin | 1 | 1993 | 109 | 0.030 |
Why?
|
| Somatostatin | 1 | 2015 | 459 | 0.030 |
Why?
|
| Glucagon | 1 | 2015 | 533 | 0.030 |
Why?
|
| Nucleocapsid Proteins | 1 | 1993 | 75 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1789 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 1997 | 995 | 0.030 |
Why?
|
| DNA, Recombinant | 3 | 1989 | 455 | 0.030 |
Why?
|
| Transcription Factor TFIID | 1 | 1993 | 149 | 0.030 |
Why?
|
| Microcirculation | 2 | 2010 | 1280 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1992 | 41 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1884 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 479 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 691 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1993 | 310 | 0.030 |
Why?
|
| Androgens | 1 | 2020 | 1279 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 4108 | 0.020 |
Why?
|
| Influenza A virus | 2 | 1993 | 453 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1467 | 0.020 |
Why?
|
| Alanine | 2 | 1996 | 612 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 220 | 0.020 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 48 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1461 | 0.020 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 84 | 0.020 |
Why?
|
| Receptors, Neurotensin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 822 | 0.020 |
Why?
|
| Heterozygote | 1 | 1998 | 2794 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2010 | 2601 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 4698 | 0.020 |
Why?
|
| Zea mays | 1 | 1992 | 110 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1991 | 141 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2011 | 194 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 306 | 0.020 |
Why?
|
| Streptozocin | 1 | 2011 | 189 | 0.020 |
Why?
|
| Hemagglutinins, Viral | 1 | 1990 | 66 | 0.020 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 230 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4348 | 0.020 |
Why?
|
| Cell-Free System | 2 | 1981 | 339 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1992 | 366 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 2012 | 176 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1886 | 0.020 |
Why?
|
| Inbreeding | 1 | 2010 | 48 | 0.020 |
Why?
|
| Age Factors | 2 | 1999 | 18380 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2004 | 591 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2010 | 46 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2010 | 41 | 0.020 |
Why?
|
| Poly A | 1 | 1990 | 180 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2011 | 362 | 0.020 |
Why?
|
| Ankle Joint | 2 | 2007 | 450 | 0.020 |
Why?
|
| Deoxyribonucleases | 3 | 1984 | 209 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2022 | 4214 | 0.020 |
Why?
|
| Biology | 1 | 2012 | 293 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 1990 | 411 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 423 | 0.020 |
Why?
|
| Cattle | 2 | 1989 | 3801 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14652 | 0.020 |
Why?
|
| Science | 1 | 2012 | 234 | 0.020 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 93 | 0.020 |
Why?
|
| Lod Score | 1 | 2010 | 598 | 0.020 |
Why?
|
| Amino Acids | 1 | 1996 | 1709 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22340 | 0.020 |
Why?
|
| Listeriosis | 1 | 2010 | 146 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1885 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 459 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1749 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1992 | 820 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 945 | 0.020 |
Why?
|
| Fungi | 1 | 1992 | 348 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 419 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 309 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 857 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 3 | 1983 | 548 | 0.020 |
Why?
|
| Horses | 1 | 1989 | 293 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 571 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 244 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 629 | 0.020 |
Why?
|
| Middle Aged | 5 | 2021 | 223004 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2476 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 618 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 340 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.020 |
Why?
|
| Proteins | 2 | 1993 | 5995 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2008 | 190 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2531 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 838 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 399 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 1067 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 394 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 297 | 0.020 |
Why?
|
| Androstadienes | 1 | 2009 | 347 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 562 | 0.020 |
Why?
|
| Blood Component Transfusion | 1 | 2008 | 138 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1997 | 2921 | 0.020 |
Why?
|
| Mitochondria | 1 | 2020 | 3673 | 0.020 |
Why?
|
| Glutamates | 1 | 1988 | 384 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 1701 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 1673 | 0.020 |
Why?
|
| Sheep | 1 | 1989 | 1440 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2394 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1957 | 0.020 |
Why?
|
| Homozygote | 1 | 1991 | 1775 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1151 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1602 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2395 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 820 | 0.020 |
Why?
|
| Chemokines | 1 | 2010 | 956 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 963 | 0.020 |
Why?
|
| Chelating Agents | 1 | 1987 | 380 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2060 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2005 | 69 | 0.020 |
Why?
|
| Data Display | 1 | 2006 | 174 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1989 | 687 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1481 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 938 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 898 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 723 | 0.010 |
Why?
|
| Dimerization | 1 | 2006 | 880 | 0.010 |
Why?
|
| Luciferases | 1 | 2006 | 713 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 739 | 0.010 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 40 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2010 | 6255 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 1993 | 1602 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3211 | 0.010 |
Why?
|
| Rats | 2 | 2012 | 23707 | 0.010 |
Why?
|
| Histamine | 1 | 2006 | 497 | 0.010 |
Why?
|
| Research | 1 | 2012 | 1975 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1659 | 0.010 |
Why?
|
| OX40 Ligand | 1 | 2003 | 57 | 0.010 |
Why?
|
| Tumor Necrosis Factors | 1 | 2003 | 109 | 0.010 |
Why?
|
| Interleukins | 1 | 2008 | 791 | 0.010 |
Why?
|
| Lentivirus | 1 | 2006 | 518 | 0.010 |
Why?
|
| Gastritis | 1 | 2005 | 200 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1993 | 3633 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1915 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2004 | 200 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2021 | 42500 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1510 | 0.010 |
Why?
|
| Tarsus, Animal | 1 | 2002 | 5 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 2832 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3089 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1988 | 1180 | 0.010 |
Why?
|
| Osteopontin | 1 | 2004 | 304 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 171114 | 0.010 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2001 | 29 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2745 | 0.010 |
Why?
|
| Micrococcal Nuclease | 2 | 1978 | 36 | 0.010 |
Why?
|
| Disease | 1 | 2007 | 676 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 1947 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1727 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 280 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2009 | 1051 | 0.010 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2003 | 157 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8733 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 256 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1370 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3624 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8102 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2942 | 0.010 |
Why?
|
| Serotonin | 1 | 2006 | 1047 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1983 | 2163 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1981 | 654 | 0.010 |
Why?
|
| Nucleosomes | 2 | 1984 | 494 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 347 | 0.010 |
Why?
|
| Arthritis, Psoriatic | 1 | 2003 | 216 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 648 | 0.010 |
Why?
|
| Incidence | 1 | 1998 | 21480 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2002 | 616 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2895 | 0.010 |
Why?
|
| Lysosomes | 1 | 2005 | 932 | 0.010 |
Why?
|
| Chemistry | 1 | 1980 | 325 | 0.010 |
Why?
|
| Viral Envelope Proteins | 2 | 1996 | 640 | 0.010 |
Why?
|
| High Mobility Group Proteins | 1 | 1980 | 180 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1980 | 483 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 2039 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4520 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4772 | 0.010 |
Why?
|
| Swine | 1 | 1989 | 5988 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3655 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3213 | 0.010 |
Why?
|
| Genes | 1 | 1983 | 1825 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 36385 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2056 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5767 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1183 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1999 | 236 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2005 | 1087 | 0.010 |
Why?
|
| Tetrahymena pyriformis | 1 | 1978 | 2 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41647 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 8927 | 0.010 |
Why?
|
| Butyrates | 1 | 1978 | 162 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 2003 | 532 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 1500 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5753 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 1981 | 549 | 0.010 |
Why?
|
| Ribosomes | 1 | 1980 | 493 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 1297 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12057 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1089 | 0.010 |
Why?
|
| Lung | 1 | 1993 | 10033 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 17075 | 0.010 |
Why?
|
| Endosomes | 1 | 1996 | 522 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 1210 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1983 | 1434 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1996 | 568 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8728 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1978 | 3067 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 933 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10729 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1990 | 259 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2003 | 2283 | 0.010 |
Why?
|
| Trypsin | 1 | 1990 | 487 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1132 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1990 | 163 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1990 | 423 | 0.010 |
Why?
|
| Immunization | 1 | 1993 | 1219 | 0.010 |
Why?
|
| Chickens | 1 | 1989 | 842 | 0.000 |
Why?
|
| Brain | 1 | 1989 | 27178 | 0.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1984 | 780 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65189 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 74836 | 0.000 |
Why?
|
| DNA Replication | 1 | 1984 | 1433 | 0.000 |
Why?
|
| Solubility | 1 | 1978 | 1078 | 0.000 |
Why?
|